Market Overview

ClearFlow Awarded Chest Drainage Products Agreement with Premier


ClearFlow, Inc., a medical device company based in Anaheim, California,
announced today that it has been awarded a group purchasing agreement
for the Chest Drainage Products category with Premier.

Effective July 15th 2018, the new agreement allows Premier
members, at their discretion, to take advantage of special pricing and
terms pre-negotiated by Premier for:

--PleuraFlow Active Clearance Technology (ACT) System;
Active Clearance Technology (ACT) System with FlowGlide; and
POD - High Capacity Dry Thoracic Drainage Canister.

"ClearFlow is proud to now be able to bring its Active Clearance
Technology devices to Premier members under these new arrangements with
one of the country's leading GPOs," said Paul Molloy, CEO of ClearFlow,
Inc. "ClearFlow's founding principles are directed toward improving
patient outcomes and lowering the total cost of healthcare for all
participants in the medical eco-system and these principles closely
align with the membership objectives of the Premier organization."

Premier is a leading healthcare improvement company, uniting an alliance
of approximately 3,900 U.S. hospitals and 150,000 other providers to
transform healthcare. With integrated data and analytics, collaborative
supply chain solutions and advisory and other services, Premier enables
better care and outcomes at a lower cost.

Chest Drainage Contract: Contract # PP-OR-1561

The PleuraFlow ACT System is indicated for use following cardiothoracic
surgical procedures and chest trauma. Its Active Clearance Technology
proactively inhibits and disrupts clot formation inside the chest tube
to reduce the likelihood of chest tube occlusion. Improving drainage by
maintaining chest tube patency has been shown to improve patient
outcomes reducing the incidence of common complications such as Pleural,
Pericardial Effusions and New Onset Post-Operative Atrial Fibrillation
(POAF). Recent data shows that reduction of the aforementioned common
complications following cardiac surgery can have a significant impact in
reducing hospital costs.

About ClearFlow, Inc.

Inc. is an Anaheim, CA based medical device company that has developed a
patented active blood and fluid evacuation system to speed recovery,
reduce complications and lower healthcare costs related to medical tube
obstruction. The company has been awarded several prestigious awards,
including the European Association of Cardiothoracic Surgeons Techno-College
Innovation Award
for a worldwide innovation that has the potential
to change the standard of care in heart and lung surgery, and the Innovations
in Cardiovascular Interventions Award
, among others.

View Comments and Join the Discussion!